A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder
Bipolar Disorders · 2024
DOI: 10.1111/bdi.13489 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Bipolar Disorders, 2024. Verfasst von Jennifer B Levin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Bipolar Disorder, Medication Adherence. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NCATS NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
Objective
Few studies have addressed medication adherence in adolescents and young adults (AYAs) with bipolar disorder (BD). This 6‐month prospective randomized‐controlled trial (RCT) tested customized adherence enhancement for adolescents and young adults (CAE‐AYA), a behavioral intervention for AYAs versus enhanced treatment as usual (ETAU).
Methods
Inclusion criteria were AYAs age 13–21 with BD type I or II with suboptimal adherence defined as missing ≥20% of medications. Assessments were conducted at Screening, Baseline, and weeks 8, 12 and 24. Primary outcome was past 7 day self‐reported Tablets Routine Questionnaire (TRQ) validated by electronic pillbox monitoring (SimpleMed). Symptom measures included the Hamilton Depression Rating Scale (HAM‐D) and Young Mania Rating Scale (YMRS).
Results
The mean sample age ( N = 36) was 19.1 years (SD = 2.0); 66.7% ( N = 24) female, BD Type I (81%). The mean missed medication on TRQ for the total sample was 35.4% (SD = 28.8) at screening and 30.4% (SD = 30.5) at baseline. Both CAE‐AYA and ETAU improved on TRQ from screening to baseline. Baseline mean missed medication using SimpleMed was 51.6% (SD = 38.5). Baseline HAM‐D and YMRS means were 7.1 (SD = 4.7) and 6.0 (SD = 7.3), respectively. Attrition rate at week 24 was 36%. Baseline to 24‐week change on TRQ, adjusting for age, gender, educational level, living situation, family history, race, and ethnicity, showed improvement favoring CAE‐AYA versus ETAU of 15%. SimpleMed interpretation was limited due to substantial missing data. There was a significant reduction in depression favoring CAE‐AYA.
Conclusions
CAE‐AYA may improve adherence in AYAs with BD, although conclusions need to be made cautiously given study limitations. Clinical Trials Registration ClinicalTrials.gov identifier: NCT04348604.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- College of Medicine, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
ORCID-Profile: Jennifer B Levin, Martha Sajatovic
Förderung
- NIMH NIH HHS
- NCATS NIH HHS
- National Institute of Mental Health
- National Center for Advancing Translational Sciences
Zitieren
APA
Levin, J. B., DelBello, M., Modi, A. C., Briggs, F., Forthun, L. F., McVoy, M., Yala, J., Cooley, R., Black, J., Conroy, C., & Sajatovic, M. (2024). A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder. Bipolar Disorders. https://doi.org/10.1111/bdi.13489
Vancouver
Levin JB, DelBello M, Modi AC, Briggs F, Forthun LF, McVoy M, et al. A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder. Bipolar Disorders. 2024. doi:10.1111/bdi.13489
BibTeX
@article{Levin2024,
author = {Levin, Jennifer B and DelBello, Melissa and Modi, Avani C and Briggs, Farren and Forthun, Larry F and McVoy, Molly and Yala, Joy and Cooley, Raechel and Black, Jessica and Conroy, Carla and Sajatovic, Martha},
title = {A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder},
journal = {Bipolar Disorders},
year = {2024},
doi = {10.1111/bdi.13489}
}
EUVIMED